SEARCH

SEARCH BY CITATION

References

  • 1
    Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med 2004; 350: 11181129.
  • 2
    Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 2007; 13: 2238.
  • 3
    Bonino F, Heermann KH, Rizzetto M, Gerlich WH. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol 1986; 58: 945950.
  • 4
    Wang CJ, Chen PJ, Wu JC, Patel D, Chen DS. Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol 1991; 65: 66306636.
  • 5
    Sureau C, Lanford R. Analysis of hepatitis B virus envelope proteins in assembly and infectivity of human hepatitis delta virus. Prog Clin Biol Res 1993; 382: 4551.
  • 6
    Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 1984; 52: 396402.
  • 7
    Le Duff Y, Blanchet M, Sureau C. The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J Virol 2009; 83: 1244312451.
  • 8
    Engelke M, Mills K, Seitz S, Simon P, Gripon P, Schnolzer M, et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. HEPATOLOGY 2006; 43: 750760.
  • 9
    Salisse J, Sureau C. A function essential to viral entry underlies the hepatitis B virus “a” determinant. J Virol 2009; 83: 93219328.
  • 10
    Sureau C, Jacob JR, Eichberg JW, Lanford RE. Tissue culture system for infection with human hepatitis delta virus. J Virol 1991; 65: 34433450.
  • 11
    Sureau C. The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model. Methods Mol Biol 2010; 640: 463473.
  • 12
    Petersen J, Dandri M, Mier W, Lutgehetmann M, Volz T, von Weizsacker F, et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 2008; 26: 335341.
  • 13
    Abou-Jaoude G, Sureau C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J Virol 2007; 81: 1305713066.
  • 14
    Zahn A, Allain JP. Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol 2005; 86: 677685.
  • 15
    Leistner CM, Gruen-Bernhard S, Glebe D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 2008; 10: 122133.
  • 16
    Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. HEPATOLOGY 2007; 46: 17591768.
  • 17
    Chai N, Chang HE, Nicolas E, Han Z, Jarnik M, Taylor J. Properties of subviral particles of hepatitis B virus. J Virol 2008; 82: 78127817.
  • 18
    Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol 2011; 3.
  • 19
    Blanchet M, Sureau C. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol 2007; 81: 58415849.
  • 20
    Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002; 99: 1565515660.
  • 21
    Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997; 4( Suppl. 1): 1120.
  • 22
    Sureau C, Fournier-Wirth C, Maurel P. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus. J Virol 2003; 77: 55195523.
  • 23
    Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289309.
  • 24
    Kalinina T, Riu A, Fischer L, Will H, Sterneck M. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. HEPATOLOGY 2001; 34: 385394.
  • 25
    Stibbe W, Gerlich WH. Characterization of pre-s gene products in hepatitis B surface antigen. Dev Biol Stand 1983; 54: 3343.
  • 26
    Levy HC, Bowman VD, Govindasamy L, McKenna R, Nash K, Warrington K, et al. Heparin binding induces conformational changes in adeno-associated virus serotype 2. J Struct Biol 2009; 165: 146156.
  • 27
    Esko JD, Linhardt RJ. Proteins that bind sulfated glycosaminoglycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, et al, editors. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2009.
  • 28
    Wounderlich G, Bruss V. Characterization of early hepatitis B virus surface protein oligomers. Arch Virol 1996; 141: 11911205.
  • 29
    Mulder AM, Carragher B, Towne V, Meng Y, Wang Y, Dieter L, et al. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine. PLoS One 2012; 7: e33235.
  • 30
    Short JM, Chen S, Roseman AM, Butler PJ, Crowther RA. Structure of hepatitis B surface antigen from subviral tubes determined by electron cryomicroscopy. J Mol Biol 2009; 390: 135141.
  • 31
    Seitz S, Urban S, Antoni C, Bottcher B. Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions. EMBO J 2007; 26: 41604167.
  • 32
    Foley EM, Esko JD. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins. Prog Mol Biol Transl Sci 2010; 93: 213233.
  • 33
    Galibert F, Chen TN, Mandart E. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol 1982; 41: 5165.
  • 34
    Cote PJ Jr, Gerin JL. Nonoverlapping antigenic sites of woodchuck hepatitis virus surface antigen and their cross-reactivity with ground squirrel hepatitis virus and hepatitis B virus surface antigens. J Virol 1983; 47: 1523.
  • 35
    Offensperger WB, Offensperger S, Walter E, Blum HE, Gerok W. Sulfated polyanions do not inhibit duck hepatitis B virus infection. Antimicrob Agents Chemother 1991; 35: 24312433.
  • 36
    Heermann KH, Gerlich WH. Surface proteins of hepatitis B viruses. In: Maclachlan A, ed. Molecular Biology of the Hepatitis B Virus. Boca Raton, FL: CRC Press; 1991: 109144.
  • 37
    Shearer MH, Sureau C, Dunbar B, Kennedy RC. Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen. Mol Immunol 1998; 35: 11491160.